Practice
Featured experience
Chime $993.6 million IPO
The shares are listed on the Nasdaq Global Select Market
Cipher Mining 300 MW, $5.5 billion lease agreement with Amazon Web Services
We advised Cipher Mining on the transaction
Diameter Capital Partners $4.5 billion fundraise for its third dislocation fund
We advised Diameter on the transaction
Banco Santander $12.2 billion acquisition of Webster Bank
We are advising Banco Santander on the transaction
GE $5.7 Billion Preferred Stock Exchange Offer
Davis Polk advised the dealer manager for General Electric Company (“GE”) in connection with the offer by GE to exchange up…
ChipMOS Taiwan merger with ChipMOS Bermuda
Davis Polk is advising ChipMOS TECHNOLOGIES INC. (“ChipMOS Taiwan”) in connection with its proposed merger with its parent…
TTX Company $300 Million Medium-Term Notes Offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A/Regulation S offering by TTX…
Crédit Agricole S.A. $1.25 Billion Undated Deeply Subordinated Additional Tier 1 Fixed-Rate Resettable Notes Offering
Davis Polk advised the managers on a Rule 144A/Regulation S offering by Crédit Agricole S.A. (“Crédit Agricole”) of $1.25…
TTX Company $300 Million Medium-Term Notes Offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A/Regulation S offering by TTX…
Crédit Agricole S.A. $1.25 Billion Undated Deeply Subordinated Additional Tier 1 Fixed-Rate Resettable Notes Offering
Davis Polk advised the managers on a Rule 144A/Regulation S offering by Crédit Agricole S.A. (“Crédit Agricole”) of $1.25…
Evergrande Real Estate Group Limited $300 Million 8.0% High-Yield Senior Notes Offering
Davis Polk advised the initial purchasers of a Regulation S offering of high-yield notes by Evergrande Real Estate Group…
Biotie acquisition by Acorda
Davis Polk is advising Biotie Therapies Corp. in connection with its combination agreement with Acorda Therapeutics, Inc…
Biotie acquisition by Acorda
Davis Polk is advising Biotie Therapies Corp. in connection with its combination agreement with Acorda Therapeutics, Inc…
Biotie acquisition by Acorda
Davis Polk is advising Biotie Therapies Corp. in connection with its combination agreement with Acorda Therapeutics, Inc…